Caroline Van Nieuwerburgh
About Caroline Van Nieuwerburgh
Caroline Van Nieuwerburgh is the Director of GSM-CT at Bristol Myers Squibb in Belgium, with extensive experience in regulatory clinical trials and team management.
Current Role at Bristol Myers Squibb
Caroline Van Nieuwerburgh is currently serving as the Director of GSM-CT at Bristol Myers Squibb in Belgium. In her role, she leads a global team responsible for preparing high-quality, risk-mitigated clinical trial packages for worldwide Health Authority and Ethics Committee submissions. She oversees a team located in three different countries, ensuring the planning and assembling of clinical trial packages in the Clinical Trials Information System (CTIS) under the new EU regulation.
Previous Experience at Register.com
Before joining Bristol Myers Squibb, Caroline worked as a Senior Account Manager at Register.com in London, Royaume-Uni, from 2000 to 2003. During her tenure, she managed client accounts and developed strong relationships with stakeholders, leveraging her expertise in operational and performance management to achieve business objectives.
Education and Expertise in Biochimie
Caroline Van Nieuwerburgh holds a Bachelor of Applied Science (BASc) in Biochimie from Paul Lambin. She studied from 1995 to 1998, where she developed a strong foundation in biochemistry, which later proved essential in her career in regulatory clinical trials and team leadership. Her educational background provides a robust scientific underpinning for her current role in clinical trials management.
Leadership and Team Management at Bristol Myers Squibb
Since joining Bristol Myers Squibb in May 2006, Caroline has demonstrated extensive experience in regulatory clinical trials, functional leadership, team development, and operational and performance management. Her role involves managing complex clinical trial operations, ensuring compliance with regulatory requirements, and fostering a collaborative team environment across multiple countries.